Point72 Asset Management, L.P. 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:15 am Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 2,613,453 4.500% | -572,624 (-17.97%) | Filing |
| 2023-12-18 4:15 pm Purchase | 2023-12-07 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 3,186,077 5.500% | 2,818,071 (+765.77%) | Filing |
| 2023-02-14 4:11 pm Sale | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 368,006 0.700% | -2,052,303 (-84.80%) | Filing |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 2,420,309 5.100% | -1,908,721 (-44.09%) | Filing |
| 2021-09-21 4:34 pm Purchase | 2021-09-20 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 4,329,030 9.100% | 4,329,030 (New Position) | Filing |